CClinicalTrials.gg
Status unknownNCT01640470CATSUpdated Apr 11, 2016

A Multi-Site Trial of the Impact of Assistive Technology With Assistance Users and Their Caregivers

A Phase 2 interventional study of Assistive Technology Provision and Tune-Up Intervention and Customary Care in Mobility Disability, Older Adults and Community Dwelling, sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal. Status unknown at 3 sites in Canada. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2016-04-11.

Sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal · Phase 2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2016), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

Many individuals with mobility limitations, especially those who are older and have more severe impairments, use a combination of assistive devices and personal assistance to meet their needs. Assistive technology (AT), which includes devices such as wheelchairs, walkers, bathroom grab bars, and dressing aids, helps facilitate day-to-day activities and social participation (basic and instrumental activities of daily living) among these individuals and may decrease their dependence on human assistance. Although some research has reported beneficial outcomes of AT use, few studies have used controlled experimental designs. Furthermore, the results are often difficult to interpret because the AT interventions are only vaguely described. Another concern is that many individuals receive help from others, but scant attention has been paid to the impact of AT on caregivers. This neglect produces an incomplete portrayal of the effect of AT interventions. The proposed study addresses these deficiencies by evaluating the effects of a formalized dyadic AT intervention on individuals with mobility limitations and on their caregivers. The Assistive Technology Provision, Updating and Training (ATPUT)intervention involves a detailed in-home assessment of participants' current AT; the negotiation and implementation of a personal AT plan with the participants and their caregivers; and the provision of AT devices, non-structural home modifications, and device training.

Objectives:

  1. To determine the efficacy of the Assistive Technology Provision, Updating and Training intervention for assistance users and for their caregivers.
  2. To explore how the intervention is experienced by these individuals and to help explain the study findings.

General Hypotheses:

The investigators anticipate this intervention will increase the daily activities and social participation of individuals with mobility limitations; decrease the psychological and physical demands on caregivers; and reduce the amount of caregiving required.

Methodologies:

This research will use a combination of quantitative and qualitative methods. The quantitative portion will be an experimental, single-blinded study in which the investigators randomly assign participants to either the ATPUT or a customary care group.

02

Conditions studied

  • Mobility Disability
  • Older Adults
  • Community Dwelling

Keywords

  • assistive technology
  • environmental modification
  • caregiver
  • client-centred
03

In context

Lead sponsor

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal is the lead sponsor of 18 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • daily activity and/or mobility disability
  • referred to homecare
  • have an unpaid informal caregiver who is above the age of consent and willing to participate in the study
  • can communicate in English or French.

Exclusion criteria

Exclusion Criteria:

  • cognitive impairments that are likely to prevent them from reliably completing the study questionnaires.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Assistive technology

    The home based AT Provision, Updating and Tune-Up (ATPUT) Intervention will include recommendations for assistive technology, possibly entailing financial assistance to repair or to acquire new AT, and training. New equipment will likely include devices such as bathroom grab bars, raised toilet seats, walkers, and bath chairs.

    Device: Assistive Technology Provision and Tune-Up Intervention

  • Active comparator
    Customary care

    Participants in this arm will receive customary care.

    Device: Customary Care

Interventions

  • DeviceAssistive Technology Provision and Tune-Up Intervention

    The home based AT Provision, Updating and Tune-Up (ATPUT) Intervention will consist of 5 components: 1) identification and prioritization of problematic activities by the assistance user and his/her principal, cohabitating caregiver; 2) in-residence assessment of the daily activities and social participation and preferences of the assistance user; 3) detailed review of the AT and human assistance that are currently being used; 4) recommendations by an occupational therapist for possible changes in the personal assistance strategy; 5) negotiation of an ATPUT Personal Plan with the assistance user and her/his principal caregiver. The intervention occurs over a six week period and involves 3 to 6 visits from an occupational therapist.

  • DeviceCustomary Care

    Participants in the customary care group receive normal occupational therapy services.Occupational Therapy

    Also known as: Customary device prescription and training

06

What researchers measure

Primary outcomes

  1. Caregiver Assistive Technology Outcome Measure

    The caregiver assistive technology outcome measure captures physical and psychological associated with informal care provision.

    Time frame: 58 Weeks

  2. Functional Autonomy Measure (Système de mesure de l'autonomie fonctionnelle (SMAF))

    A composite from two sub-scales of the SMAF will be used the primary outcome measure for users (self-care and mobility)

    Time frame: 58 weeks

Secondary outcomes

  1. Sub-scale scores from the Functional Autonomy Measure (Système de mesure de l'autonomie fonctionnelle (SMAF))

    Three sub-scales from the Functional Autonomy Measure (Système de mesure de l'autonomie fonctionnelle (SMAF)) (self-care, mobility and instrumental) will be used as secondary outcome measures for assistance users.

    Time frame: baseline (Time 0), week 6 (Time 1), week 22 (Time 2) and at week 58 (Time 3)

  2. Sub-scale scores from the Caregiver Assistive Technology Outcome Measure

    For caregivers, sub-scale scores of frequency of physical and psychological burden from the CATOM will be used.

    Time frame: baseline (Time 0), week 6 (Time 1), week 22 (Time 2) and at week 58 (Time 3).

  3. Euro-QOL 5

    For caregivers, health-related quality of life. Health related quality of life will be measured using the EuroQol,

    Time frame: baseline (Time 0), week 6 (Time 1), week 22 (Time 2) and at week 58 (Time 3).

  4. Caregiver Burden Inventory

    A composite score from the first three subscales of the Caregiver Burden Inventory will be used as a secondary outcome measure for caregivers.

    Time frame: baseline (Time 0), week 6 (Time 1), week 22 (Time 2) and at week 58 (Time 3).

  5. Reintegration to Normal Living Index (RNLI)

    The RNLI will measure problems with social participation among assistance users.

    Time frame: baseline (Time 0), week 6 (Time 1), week 22 (Time 2) and at week 58 (Time 3).

  6. Self-report of Functional Independence

    Assistance users and caregivers will independently evaluate perceived functional Independence of assistance users.

    Time frame: baseline (Time 0), week 6 (Time 1), week 22 (Time 2) and at week 58 (Time 3).

  7. Qualitative interviews

    A purposive sample of participants will be interviewed immediately after the intervention and at the end of the study to understand better how the intervention was administered by therapists and experienced by assistance users and their caregivers.

    Time frame: week 6 and week 58

07

Study locations

3 sites
  • Simon Fraser University- Gerontolgy Research Centre
    Vancouver, British Columbia V6B 5K3, Canada
  • Élisabeth Bruyère Research Centre
    Ottawa, Ontario K1N 5C8, Canada
  • University of Montreal
    Montreal, Quebec H3W 1W5, Canada
08

References and documents

Publications

  • Ben Mortenson W, Demers L, Fuhrer MJ, Jutai JW, Bilkey J, Plante M, DeRuyter F. Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial. BMC Geriatr. 2018 Apr 18;18(1):97. doi: 10.1186/s12877-018-0783-6. PubMed 29669536 ↗
  • Demers L, Mortenson WB, Fuhrer MJ, Jutai JW, Plante M, Mah J, DeRuyter F. Effect of a tailored assistive technology intervention on older adults and their family caregiver: a pragmatic study protocol. BMC Geriatr. 2016 May 13;16:103. doi: 10.1186/s12877-016-0269-3. PubMed 27177609 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01640470
Lead sponsor
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Collaborators
Simon Fraser University, Duke University, University of Ottawa
Responsible party
Louise Demers (Directrice, Département de l'ergothérapie, Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal) — Principal investigator
First posted
Jul 13, 2012
Start date
Dec 2011
Primary completion
May 2016 (estimated)
Completion
Mar 2017 (estimated)
Last update
Apr 11, 2016

Study contacts

Louise Demers, PhD
principal investigator · Université de Montréal

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion